Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Permissive Cardiotoxicity: Real World Outcomes of CAR-T Therapy in Patients with Heart Failure and Reduced Ejection Fraction | Synapse
March 3, 2026
Permissive Cardiotoxicity: Real World Outcomes of CAR-T Therapy in Patients with Heart Failure and Reduced Ejection Fraction
SL
Sree M Lanka
The Ohio State University
SC
Sayan Mullick Chowdhury
JS
Jeremy Sen
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Ver todo
Puntos clave
Cardiotoxicity rates increased, with significant implications for heart failure management and patient care,
The study reports a 40% incidence of cardiotoxicity related to CAR-T therapy in heart failure patients,
Observational analysis of real-world outcomes across multiple facilities highlights varied responses to treatment,
Findings may enable better monitoring strategies and tailored interventions for heart failure patients under CAR-T therapy.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Lanka et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76028c6e9836116a2ca0e
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.242